載入...
Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers
AIMS: To compare the lipid-regulating effects and steady-state pharmacokinetics of rosuvastatin, a new synthetic hydroxy methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, following repeated morning and evening administration in volunteers with fasting serum low-density lipoprotein cholesterol...
Na minha lista:
Main Authors: | , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Blackwell Science Inc
2002
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1874466/ https://ncbi.nlm.nih.gov/pubmed/12445025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2002.01688.x |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|